Diabetes and deafness

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Diabetes and deafness | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Hyperglycemia, Hearing loss |
| Complications | Cardiovascular disease, Neuropathy, Retinopathy |
| Onset | Varies, often in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation in mitochondrial DNA |
| Risks | Family history of mitochondrial disorders |
| Diagnosis | Genetic testing, Audiometry, Blood glucose test |
| Differential diagnosis | Type 1 diabetes, Type 2 diabetes, Syndromic deafness |
| Prevention | N/A |
| Treatment | Insulin therapy, Hearing aids, Cochlear implants |
| Medication | N/A |
| Prognosis | Varies, depends on management of symptoms |
| Frequency | Rare |
| Deaths | N/A |
Diabetes and deafness is a condition that is often associated with certain genetic syndromes, particularly those involving mitochondrial inheritance. This condition can manifest as part of a syndrome where both diabetes mellitus and sensorineural hearing loss are present.
Mitochondrial Inheritance[edit]
Diabetes and deafness can be linked to mutations in the mitochondrial DNA (mtDNA). Mitochondria are the energy-producing organelles within cells, and they have their own DNA, which is inherited maternally. This means that conditions caused by mutations in mtDNA, such as diabetes and deafness, are passed from mothers to their children. Mitochondrial inheritance is characterized by the fact that only the ovum contributes mitochondria to the embryo, while the sperm does not. Therefore, all offspring of an affected mother may inherit the condition, while none of the offspring of an affected father will.
Clinical Features[edit]
The combination of diabetes and deafness can be seen in several mitochondrial syndromes, such as Maternally Inherited Diabetes and Deafness (MIDD). In these cases, diabetes is typically of the non-insulin-dependent diabetes mellitus (NIDDM) type, although it can progress to require insulin treatment. The hearing loss associated with these conditions is usually sensorineural, meaning it is due to problems in the inner ear or the auditory nerve. This type of hearing loss is often progressive and can vary in severity.
Genetic Mutations[edit]
Several specific mutations in the mitochondrial genome have been associated with diabetes and deafness. One of the most common mutations is the A3243G mutation in the MT-TL1 gene, which affects the tRNA for leucine. This mutation is also associated with other mitochondrial disorders, such as MELAS syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes).
Diagnosis and Management[edit]
Diagnosis of diabetes and deafness due to mitochondrial mutations involves genetic testing to identify specific mtDNA mutations. Management of the condition includes regular monitoring and treatment of diabetes, as well as audiological assessments and interventions for hearing loss.
Prognosis[edit]
The prognosis for individuals with diabetes and deafness due to mitochondrial mutations varies depending on the specific mutation and the severity of the symptoms. Early diagnosis and management can help improve quality of life and reduce complications.
See also[edit]
| Mitochondrial diseases | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
see also mitochondrial proteins
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian